Connection

Dingwei Zhao to Xenograft Model Antitumor Assays

This is a "connection" page, showing publications Dingwei Zhao has written about Xenograft Model Antitumor Assays.
  1. Enhancing the efficacy of B7-H3-targeting antibody-drug conjugate DS-7300a in TP53-deficient tumors by inducing ferroptosis. Oncogene. 2026 Sep; 45(36):3753-3764.
    View in: PubMed
    Score: 0.193
  2. CHD1 loss reprograms SREBP2-driven cholesterol synthesis to fuel androgen-responsive growth and castration resistance in SPOP-mutated prostate tumors. Nat Cancer. 2025 May; 6(5):854-873.
    View in: PubMed
    Score: 0.177
  3. Symbiotic Macrophage-Glioma Cell Interactions Reveal Synthetic Lethality in PTEN-Null Glioma. Cancer Cell. 2019 06 10; 35(6):868-884.e6.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.